Tomasz Gólczewski

Tomasz Gólczewski

Auto-generated profile, based on publicly available information

Tomasz Gólczewski

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Respiratory Research
Verified
Journal Article
Open access
PDF file
TGTomasz Gólczewski
Tomasz Gólczewski
WLWojciech Lubiński
Wojciech Lubiński
ACAndrzej Chcialowski
Andrzej Chcialowski
Recent studies have showed that FEV1/FVC describing correspondence between the forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) depends significantly on age. However, the nature of this dependence is uncertain. The study aim is to analyze mathematically the relationship between FEV1 and FVC to find a cause of the FEV1/FVC dependence on age in healthy subjects.

1 October 2006 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
TGT. Golczewski
T. Golczewski
MDM. Darowski
M. Darowski
Background: Due to economic and ethical problems, virtual organs may appear more convenient than experiments on animals or limited investigations on patients. In particular, a virtual respiratory system (VRS) may be useful for tasks such as respirators and support methods testing, education, staff (medical and technical) training, (initial) testing of scientific hypotheses. Methods: A comparative study of simulated and real spirometric results for different patient states (healthy lungs, restrictive lung disease, and obstructive lung disease of different localization and degree) was performed. The volume-flow curve and such standard parameters as FEV1, FEV1%VC, MEF75 etc. were analyzed. Results: A mathematical description of collapsing bronchi was proposed. All fundamental phenomena present during spirometry also appeared in VRS, especially characteristic dependence between lung volume and air flow for forced expiration. In particular, both airway resistance and the flow limitation were described with one formula derived from commonly known dependence of the resistance on lung volume. Generally there were no significant differences between simulated results and those seen in clinical practice. Only simulation of obstruction in upper airways gave incorrect results, which suggested a different flow limitation mechanism (perhaps wave-speed limitation). Conclusions: Our VRS can already be used in medical education, e.g. courses of spirometry, and in some other applications. It seems that the significance of the wave-speed criterion has been overestimated.

16 July 2007 in Nonlinear Biomedical Physics
Verified
Journal Article
Open access
TGTomasz Golczewski
Tomasz Golczewski
MDMarek Darowski
Marek Darowski
Continuous Positive Airway Pressure (CPAP) is a commonly accepted method of spontaneous breathing support in obstructive lung disease. Previous work suggested that the cause of the CPAP efficacy in the obstructive lung disease localized in bronchi of middle order (OLDMO) is not as obvious as, for example, in the obstructive sleep apnea. Since CPAP reduces obstruction and the optimal breathing frequency (BF) depends on the obstruction level, it seems to be important to analyze the dependence of the optimal BF on CPAP. To analyze the support efficacy cause in OLDMO, esp. the relationship between the CPAP value and optimal BF. Investigations utilized previously built virtual respiratory system. Its most important factors: nonlinear lungs compliance and changeability of nonlinear airway resistance (Raw). Influence of BF and the CPAP value on the tidal volume and minute ventilation was analyzed for four exemplary virtual patients: healthy ("standard") and suffering from moderate, severe, and the very severe OLDMO (the other parameters, esp. respiratory muscles effort, were unchanged). Minute inspiratory work as a criterion of the BF optimization. CPAP decreased Raw making breathing easier, however, it shifted the working point of the respiratory system towards the smaller lungs compliance making breathing harder. The final result depended on the Raw value: CPAP improved breathing of patients with the serious OLDMO while it worsened healthy person breathing. The optimal CPAP value depended on the Raw value. If a virtual patient suffering from the serious OLDMO was not supported with CPAP, he had to breathe with low frequency because minute ventilation did not rise with BF increase. The optimal BF depended on the CPAP value (the greater the value, the greater the frequency). The CPAP efficacy depends on the level of OLDMO. CPAP is efficient in the severe OLDMO because it increases the optimal BF, which makes possible less energy-consuming breathing with frequency close to the normal one (greater BF means smaller tidal volume and thus smaller work against lungs compliance).

1 May 2010 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
WLWojciech Lubiński
Wojciech Lubiński
TGTomasz Gólczewski
Tomasz Gólczewski
The need for ethnic-specific reference values of lung function variables (LFs) is acknowledged. Their estimation requires expensive and laborious examinations, and therefore additional use of results in physiology and epidemiology would be profitable. To this end, we proposed a form of prediction equations with physiologically interpretable coefficients: a baseline, the onset age (A0) and rate (S) of LF decline, and a height coefficient. The form was tested with data from healthy, nonsmoking Poles aged 18–85 yr (1,120 men, 1,625 women) who performed spirometry maneuvers according to American Thoracic Society criteria. The values of all the coefficients (also A0) for several LFs were determined with regression of LF on patient's age and deviation of patient's height from the mean height in the year group of this patient. S values for forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), peak expiratory flow, and maximal expiratory flow at 75% of FVC (MEF75) were very similar in both sexes (1.03 ± 0.07%/yr). FEV1/FVC declines four to five times slower. S for MEF25 appeared age dependent. A0 was smallest (28–32 yr) for MEF25 and FEV1. About 50% of each age subgroup (18–40, 41–60, 61–85 yr) exhibited LFs below the mean, and 4–6% were below the 5th percentile lower limits of normal, and thus the form of equations proposed in the paper appeared appropriate for spirometry. Additionally, if this form is accepted, epidemiological and physiological comparison of different LFs and populations will be possible by means of direct comparison of the equation coefficients.

1 September 2011 in Respiration
Verified
Journal Article
Open access
PDF file
RKRafal Krenke
Rafal Krenke
MGMaciej Guć
Maciej Guć
EGElżbieta Magdalena Grabczak
Elżbieta Magdalena Grabczak
MMMarcin Michnikowski
Marcin Michnikowski
KPKrzysztof Jakub Pałko
Krzysztof Jakub Pałko
TGTomasz Gólczewski
Tomasz Gólczewski
Background: Measurement of intrapleural pressure is useful during various pleural procedures. However, a pleural manometer is rarely available. Objectives: The aim of this study was to (1) construct an electronic pleural manometer, (2) assess the accuracy of the measurements done with the new device, (3) calculate the costs of the manometer construction and (4) perform an initial evaluation of the device in a clinical setting. Methods: Only widely accessible elements were used to construct the device. A vascular pressure transducer was used to transform pressure into an electronic signal. Reliability of the measurements was evaluated in a laboratory setting in a prospective, single-blind manner by comparing the results with those measured by a water manometer. Functionality of the device was assessed during therapeutic thoracentesis. The cost of the new pleural manometer was calculated. Results: We built a small, portable device which can precisely measure intrapleural pressure. The measurement results showed very high agreement with those registered with a water manometer (r = 0.999; p < 0.001). The initial evaluation of the electronic manometer during therapeutic thoracentesis showed it was easy to use. The total time needed for 6 measurements after withdrawal of different volumes of pleural fluid in 1 patient did not exceed 6 min. The total cost of the device was calculated to be <2,000 EUR. Conclusions: In the face of very limited offer of commercially available pleural manometers, it is possible to successfully construct a self-made, reliable, electronic pleural manometer at modest costs. The device is easy to use and enables data display and storage in the personal computer.

3 November 2014 in Respirology
Verified
Journal Article
Closed access
PDF file
MZMonika Zielinska‐Krawczyk
Monika Zielinska‐Krawczyk
MMMarcin Michnikowski
Marcin Michnikowski
EGElzbieta M. Grabczak
Elzbieta M. Grabczak
KPKrzysztof J. Palko
Krzysztof J. Palko
PKPiotr Korczynski
Piotr Korczynski
RKRafal Krenke
Rafal Krenke